Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patients

European Journal of Cancer

Volumn 71, Issue , 2017, Pages 70-79

  Loquai, Carmen ^a   Dechent, Dagmar ^b   Garzarolli, Marlene ^c   Kaatz, Martin ^d   Kaehler, Katharina C ^e   Kurschat, Peter ^f   Meiss, Frank ^g   Micke, Oliver ^h   Muecke, Ralph ⁱ   Muenstedt, Karsten ^j   Stein, Annette ^k   Nashan, Dorothée ^l   Stoll, Christoph ^m   Schmidtmann, Irene ^a   Huebner, Jutta ⁿ  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d Wald Klinikum Gera   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f UNIVERSITY OF COLOGNE   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

^h FRANZISKUS HOSPITAL   (Germany)

ⁱ RUHR UNIVERSITY BOCHUM   (Germany)

^j Medical Clinic II   (Germany)

^k Practice of Dermatology   (Germany)

^l KLINIKUM DORTMUND   (Germany)

^m Clinic Herzoghoehe Bayreuth   (Germany)

ⁿ GOETHE UNIVERSITY   (Germany)

more..

Author keywords

Complementary and alternative medicine; Melanoma; Patient needs

Indexed keywords

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SUSCEPTIBILITY; CANCER THERAPY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; FEMALE; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA SKIN CANCER; MULTICENTER STUDY; PATIENT SAFETY; PATIENT SATISFACTION; PHYSICAL ACTIVITY; POLLUTANT; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; SELF HELP; SOCIAL SUPPORT; ATTITUDE TO HEALTH; CLINICAL TRIAL; GERMANY; MELANOMA; MIDDLE AGED; PATIENT ATTITUDE; PROCEDURES; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UTILIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOGISTIC MODELS; MELANOMA; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 85004011316     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2016.10.029     Document Type: Article

References (30)

1. [1] Eardley, S., Bishop, F.L., Prescott, P., Cardini, F., Brinkhaus, B., Santos-Rey, K., et al. A systematic literature review of complementary and alternative medicine prevalence in EU. Forsch Komplementmed 19:s2 (2012), 18–28.
2. [2] Molassiotis, A., Fernandez-Ortega, P., Pud, D., Ozden, G., Scott, J.A., Panteli, V., et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16 (2005), 655–663.
3. [3] Horneber, M., Bueschel, G., Dennert, G., Less, D., Ritter, E., Zwahlen, M., How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 11 (2012), 187–203.
4. [4] Micke, O., Bruns, F., Glatzel, M., Schönekaes, K., Micke, P., Mücke, R., et al. Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology. Eur J Integr Med 1 (2009), 22–30.
5. [5] Huebner, J., Micke, O., Muecke, R., Buentzel, J., Prott, F.J., Kleeberg, U., et al. User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German Comprehensive Cancer Center. Anticancer Res 34 (2014), 943–948.
6. [6] Muenstedt, K., Duetemeyer, V., Huebner, J., Patients’ considerations behind the use of methods from complementary and alternative medicine in the field of obstetrics in Germany. Arch Gynecol Obstet 288 (2013), 527–530.
7. [7] Huebner, J., Muenstedt, K., Prott, F.J., Stoll, C., Micke, O., Buentzel, J., et al. Online survey of patients with breast cancer on complementary and alternative medicine. Breast Care 9 (2014), 60–63.
8. [8] Ott, I.M., Muenstedt, K., Micke, O., Muecke, R., Prott, F.J., Senf, B., et al. Attitude of oncology/haematology nurses from German speaking countries towards complementary and alternative medicine. Trace Elements Electrolyt 32 (2015), 74–80.
9. [9] Conrad, C., Muenstedt, K., Micke, O., Prott, F., Gronau, T., Muecke, R., et al. Survey of members of the German Society for Palliative Medicine regarding their attitudes towards complementary and alternative medicine for cancer patients. J Cancer Res Clin Oncol 140 (2014), 1229–1237.
10. [10] Trimborn, A., Senf, B., Muenstedt, K., Buentzel, J., Micke, O., Muecke, R., et al. Attitude of employees of a university clinic to complementary and alternative medicine in oncology. Ann Oncol 24 (2013), 2641–2645.
11. [11] Huebner, J., Mohr, P., Simon, J.C., Fluck, M., Berking, C., Zimmer, L., et al. Usage of complementary medicine in metastatic melanoma patients treated with ipilimumab within a clinical trial. J Dtsch Dermatol Ges 14 (2016), 508–513.
12. [12] Paul, M., Davey, B., Senf, B., Stoll, C., Münstedt, K., Mücke, R., et al. Patients with advanced cancer and their usage of complementary and alternative medicine. J Cancer Res Clin Oncol 130 (2013), 1515–1522.
13. [13] Zeller, T., Muenstedt, K., Stoll, C., Schweder, J., Senf, B., Ruckhaeberle, E., et al. Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol 139 (2013), 357–365.
14. [14] Miller, P.E., Vasey, J.J., Short, P.F., Hartman, T.J., Dietary supplement use in adult cancer survivors. Oncol Nurs Forum 36 (2009), 61–68.
15. [15] Eschiti, V.S., Lesson from comparison of CAM use by women with female-specific cancers to others: it's time to focus on interaction risks with CAM therapies. Integrat Cancer Ther 6 (2007), 313–344.
16. [16] Vapiwala, N., Mick, R., Hampshire, M.K., Metz, J.M., DeNittis, A.S., Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer 12 (2006), 467–474.
17. [17] Naing, A., Stephen, S.K., Frenkel, M., Chandhasin, C., Hong, D.S., Lei, X., et al. Prevalence of complementary medicine use in a phase 1 clinical trial: the MD Anderson Cancer Center experience. Cancer 117:22 (2011), 5142–5150.
18. [18] Huebner, J., Muenstedt, K., Muecke, R., Counseling cancer patients on complementary and alternative medicine. Strahlenther Onkol 189 (2013), 613–617.
19. [19] Engdal, S., Steinsbekk, A., Klepp, O., Nilsen, O.G., Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway. Supp Care Cancer 16 (2008), 763–769.
20. [20] Sewitch, M.J., Rajput, Y., A literature review of complementary and alternative medicine use by colorectal cancer patients. Compl Ther Clin Pract 16 (2010), 52–56.
21. [21] Tautz, E., Momm, F., Hasenburg, A., Guethlin, C., Use of complementary and alternative medicine in breast cancer patients and their experiences: a cross-sectional study. Eur J Cancer 48 (2012), 3133–3139.
22. [22] Garland, S.N., Valentine, D., Desai, K., Li, S., Langer, C., Evans, T., et al. Complementary and alternative medicine use and benefit finding among cancer patients. J Altern Complement Med 19 (2013), 876–881.
23. [23] Ebel, M.D., Rudoph, I., Keinki, C., Hoppe, A., Muecke, R., Micke, O., et al. Perception of cancer patients of their disease, of self-efficacy and locus of control and usage of complementary and alternative medicine. J Cancer Res Clin Oncol 141 (2015), 1449–1455.
24. [24] Kleeberg, U.R., Suciu, S., Bröcker, E.B., Ruiter, D.J., Chartier, C., Liénard, D., et al. Final result of the EORTC 8871/DKG 80-1 randomised phase II trial. Eur J Cancer 40 (2004), 390–402.
25. [25] S3 – Leitlinie “Diagnostik, Therapie und Nachsorge des Melanoms” Version 1.1-Februar 2013; AWMF-Register-Nummer: 032-024OL.
26. [26] Henf, A., Wesselmann, S., Huthmann, D., Muenstedt, K., Huebner, J., Complementary and alternative medicine in German Cancer Centers. Oncol Res Treat 37 (2014), 390–394.
27. [27] Gorski, D.H., Integrative oncology: really the best of both worlds?. Nat Rev Cancer 14 (2014), 692–700.
28. [28] Seely, D.M., Weeks, L.C., Young, S., A systematic review of integrative oncology programs. Curr Oncol 19:6 (2012), e436–e461.
29. [29] Weeks, L.C., Seely, D., Balneaves, L.G., Boon, H.S., Leis, A., Oneschuk, D., et al. Canadian integrative oncology research priorities: results of a consensus-building process. Curr Oncol 20:4 (2013), e289–e299.
30. [30] Huebner, J., Senf, B., Micke, O., Muecke, R., Stoll, C., Prott, F.J., et al. Online information on complementary and alternative medicine for cancer patients: evidence-based recommendations. Oncol Res Treat 36 (2013), 273–278.